Security key
36315X101
Lakefront Biotherapeutics NV - Ordinary shares, no nominal value per share (the "Ordinary Shares") (LKFT)
CUSIP: 36315X101
Q1 2018 13F Holders as of 31 Mar 2018
- Security type / class
- Equity / Ordinary shares, no nominal value per share (the "Ordinary Shares")
- Total 13F shares
- 8,967,419
- Total 13F value
- $894,285,000
- Share change
- -971,953
- Put/Call ratio
- 161%
- SEC-reported price per share
- $99.76
- Number of holders
- 81
- Value change
- -$95,785,246
- Number of buys
- 36
- Number of sells
- 33
- Shares outstanding
- 65,567,327
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2018
Institutions
81
Top holders
10
LKFT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Lakefront Biotherapeutics NV SEC filings
Lakefront Biotherapeutics NV company facts
Broader feeds
Reporting periods
Holder history for CUSIP 36315X101
Recent filing periods:
Ownership snapshot
Top reported holders of LKFT - Lakefront Biotherapeutics NV - Ordinary shares, no nominal value per share (the "Ordinary Shares") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
31 Dec 2017
13F
Lead comparable stake: 3.8%
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 3.8%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Comparable ownership
Top 5
FMR LLC
3.8%
SANDS CAPITAL MANAGEMENT, LLC
3%
FEDERATED HERMES, INC.
2.1%
ORBIMED ADVISORS LLC
0.74%
BlackRock Finance, Inc.
0.53%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
3.8%
|
$235,431,000
2,510,992 shares
|
— | 31 Dec 2017 |
| SANDS CAPITAL MANAGEMENT, LLC |
13F
Company
|
3%
|
$187,362,000
1,998,311 shares
|
— | 31 Dec 2017 |
| FEDERATED HERMES, INC. |
13F
Company
|
2.1%
|
$126,626,000
1,350,534 shares
|
— | 31 Dec 2017 |
| ORBIMED ADVISORS LLC |
13F
Company
|
0.74%
|
$45,660,000
486,990 shares
|
— | 31 Dec 2017 |
| BlackRock Finance, Inc. |
13F
Company
|
0.53%
|
$32,516,000
346,802 shares
|
— | 31 Dec 2017 |
| FARALLON CAPITAL MANAGEMENT, L.L.C. |
13F
Company
|
0.44%
|
$27,190,000
290,000 shares
|
— | 31 Dec 2017 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2018
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
81
Shares
8,967,419
Rows available
81
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2018 vs Q1 2018 Across Filers
Q1 2018 holders
81
Q1 2018 holders
81
Holder diff
0
| Investor | Q1 2018 Shares | Q1 2018 Shares | Share Diff | Share Chg % | Q1 2018 value | Q1 2018 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend